Regulator weighs inspection of drug-making facilities in US
According to the proposal, the sites will be inspected if they have made substandard drugs, received quality complaints, or faced action by other regulatory authorities.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Pharmaceuticals